The Advisory Committee on Immunization Practices (ACIP), a group of U.S. health experts, has issued a formal recommendation for adults with weakened immune systems. They advise that immunocompromised people aged 19 and older should get two doses of the recombinant zoster vaccine (RZV) to help prevent shingles and related health problems.
This recommendation is based on the committee's review of existing evidence about the vaccine and the higher risk of shingles in people with compromised immune systems. The report does not include new data on how well the vaccine works specifically in this group or details about potential side effects.
It is important to understand that this is an official guideline from a health panel, not the result of a new clinical trial. The recommendation is meant to guide doctors and patients in making decisions. If you have a weakened immune system, you should talk with your healthcare provider about whether this vaccine is right for your specific situation and health status.